5VA-12613-43143 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-28
Dose 1 — Pfizer-BioNTech
2021-02-18
Dose 2 — Pfizer-BioNTech
2021-12-16
Dose 3 — Pfizer-BioNTech
2021-12-17
Registered in v-safe
2021-12-17
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site pain — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches

Free text: Tenderness at injection site.

MedDRA releases: 2024-11 · check-in free text available
2021-12-19
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site pain, Injection site warmth — Feeling: Good

Free text: Very slight tenderness at injection site and feels warm.

MedDRA releases: 2024-11 · check-in free text available
2021-12-20
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-21
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site warmth — Feeling: Good

Free text: Feels warm at injection site.

MedDRA releases: 2024-11 · check-in free text available
2021-12-22
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site warmth — Feeling: Good

Free text: Still feels warm at injection site.

MedDRA releases: 2024-11 · check-in free text available
2021-12-25
Health check-in — day 7, dose 3
Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-01-01
Survey response — day 14, dose 3
MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activities

Free text: A period of extreme fatigue last night.

MedDRA releases: 2024-11 · check-in free text available
2022-01-06
Survey response — day 21, dose 3
MedDRA: Chills, Cold sweat, Fatigue, Headache, Hyperhidrosis, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fatigue, chest congestion & periods of chills followed by perspiring with clammy hands with more chills. Also a mild headache.

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Survey response — day 28, dose 3
MedDRA: Fatigue, Intestinal haemorrhage, Medical counselling — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Still experiencing some fatigue and recently had some intestinal bleeding · Healthcare visit (other): Contacted doctor by phone, received medication and had to stop warfarin. Further test scheduled.

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Report sent to call center — day 28, dose 3
Get care from a doctor or other healthcare professional

1 call case(s)
2022-01-18
Call 1 — Left Voicemail
2022-01-20
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-29
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-06-18
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-16
Survey response — 12 months, dose 3
MedDRA: Cardiac disorder, Cardiac stress test abnormal, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: I had some heart symptoms that lead to an abnormal Echo Stress test which resulted in the need for a Cardiac CATH. · Healthcare visit (other): An appointment with my Cardiologist

MedDRA releases: 2024-11 · check-in free text available
2022-12-16
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2022-12-19
Call successful
Participant prefers to complete VAERS report online
2022-12-19
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-28	Pfizer-BioNTech	No
2	2021-02-18	Pfizer-BioNTech	No
3	2021-12-16	Pfizer-BioNTech	No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-17

Systemic reaction (other): Tenderness at injection site.

2021-12-19

Systemic reaction (other): Very slight tenderness at injection site and feels warm.

2021-12-21

Systemic reaction (other): Feels warm at injection site.

2021-12-22

Systemic reaction (other): Still feels warm at injection site.

Release 10 — day 14, dose 3

2022-01-01

Symptoms: A period of extreme fatigue last night.

Release 10 — day 21, dose 3

2022-01-06

Symptoms: Fatigue, chest congestion & periods of chills followed by perspiring with clammy hands with more chills. Also a mild headache.

Release 10 — day 28, dose 3

2022-01-13

Symptoms: Still experiencing some fatigue and recently had some intestinal bleeding

Healthcare visit (other): Contacted doctor by phone, received medication and had to stop warfarin. Further test scheduled.

Release 12 — 12 months, dose 3

2022-12-16

Symptoms: I had some heart symptoms that lead to an abnormal Echo Stress test which resulted in the need for a Cardiac CATH.

Healthcare visit (other): An appointment with my Cardiologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical counselling	·	·	✓
HCVO	Office visit	·	·	✓
SD	Cardiac disorder	·	·	✓
SD	Cardiac stress test abnormal	·	·	✓
SD	Chills	·	·	✓
SD	Cold sweat	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Hyperhidrosis	·	·	✓
SD	Intestinal haemorrhage	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SRO	Injection site pain	·	·	✓
SRO	Injection site warmth	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release